GIST is characterized by mutually exclusive gain-of-function mutations in KIT and platelet-derived growth factor receptor alpha (PDGFRA) oncogenes in ~ 85% of cases [1, 3]. The gene discussed is PDGFRA; the disease is gastrointestinal stromal tumor.